. . . . . . . "[These findings clearly show that NF-?B activation is a novel target of oncogenic KRAS in endometrial carcinogenesis, implying the potential utility of NF-?B inhibitors for endometrial cancer chemoprevention, especially with KRAS mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:59+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .